These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10392016)

  • 21. Femoral head collection for bone graft.
    Neve G
    Br J Theatre Nurs; 1996 Jul; 6(4):32-3. PubMed ID: 8850878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow screening: successful program.
    Alvarez DH; Hewitt JB
    AAOHN J; 1995 Jul; 43(7):376-8. PubMed ID: 7612082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of donor-reactive cells as a new conditioning regimen for allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Slavin S
    Transplant Proc; 2007 Apr; 39(3):678-84. PubMed ID: 17445572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unrelated cord blood transplant as salvage following non-engraftment of unrelated marrow transplant?
    Shaw PJ; Bleakley M; Lau L
    Bone Marrow Transplant; 2004 Aug; 34(3):275-6. PubMed ID: 15156168
    [No Abstract]   [Full Text] [Related]  

  • 26. Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.
    Schleuning M; Günther W; Tischer J; Ledderose G; Kolb HJ
    Bone Marrow Transplant; 2003 Aug; 32(3):243-50. PubMed ID: 12858194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
    Takami A; Chuhjo T; Nakao S
    Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
    [No Abstract]   [Full Text] [Related]  

  • 28. Bone marrow transplants come of age. New hope for deadly diseases.
    Meadows M
    FDA Consum; 2000; 34(4):22-7. PubMed ID: 11924631
    [No Abstract]   [Full Text] [Related]  

  • 29. Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers.
    van Pel M; van Breugel DW; Vos W; Ploemacher RE; Boog CJ
    Bone Marrow Transplant; 2003 Jul; 32(1):15-22. PubMed ID: 12815473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Allogeneic transplantation of stem cells].
    Einsele H; Kanz L
    Internist (Berl); 1999 Dec; 40(12):1249-56. PubMed ID: 10642911
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved results in marrow transplantation from unrelated donors. Genoa BMT Group.
    Bacigalupo A; Lamparelli T; Barbanti M; Sacchi N; Battista Ferrara G; Pozzi S; Bregante S; Mordini N; Vitale V; Van Lint MT
    Haematologica; 1999 Jun; 84 Suppl EHA-4():50-2. PubMed ID: 10907467
    [No Abstract]   [Full Text] [Related]  

  • 33. [Allogeneic bone marrow transplantation with a nonmyeloablative conditioning regimen in a patient with acute myeloblastic leukemia].
    Rossiev VA; Aleksandrova IIa; Lipshina SR; Stukalova TA; Savchenko VG
    Ter Arkh; 2000; 72(7):67. PubMed ID: 10983326
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced intensity conditioning bone marrow transplantation for pure red cell aplasia: successful outcome but difficult post transplant course.
    Kochethu G; Baden HS; Jaworska E; Chang J; Chopra R
    Bone Marrow Transplant; 2005 Jul; 36(1):81-2. PubMed ID: 15895117
    [No Abstract]   [Full Text] [Related]  

  • 35. National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants.
    Hurley CK; Baxter Lowe LA; Logan B; Karanes C; Anasetti C; Weisdorf D; Confer DL
    Biol Blood Marrow Transplant; 2003 Oct; 9(10):610-5. PubMed ID: 14569557
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of JMML with related bone marrow transplantation after reduced-intensity conditioning.
    Koyama M; Nakano T; Takeshita Y; Sakata A; Sawada A; Yasui M; Okamura T; Inoue M; Kawa K
    Bone Marrow Transplant; 2005 Sep; 36(5):453-4; author reply 454. PubMed ID: 15968292
    [No Abstract]   [Full Text] [Related]  

  • 37. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The South African bone marrow registry (SABMR) in 2004.
    du Toit ED; Borrill V; Schlaphoff TE
    Transfus Apher Sci; 2005 Feb; 32(1):25-6. PubMed ID: 15737870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donors.
    Schattenberg A; van der Meer A; Preijers F; Schaap N; Rinkes M; van der Maazen R; Allebes W; Joosten I; De Witte T
    Bone Marrow Transplant; 2004 Jun; 33(11):1115-21. PubMed ID: 15064694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.